Get started
Author

Célestin Bigarré

Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre‐ and on‐Treatment Prognostic Biomarkers
2024 · Sébastien Benzekry, Mélanie Karlsen, et al. · Clinical Pharmacology & Therapeutics · 10
PDF
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers
2023 · Célestin Bigarré, François Bertucci, et al. · Computer Methods and Programs in Biomedicine · 5
Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of Immunotherapy
2024 · Alice Daumas, Celestin Bigarre, et al. · Cancers · 2
PDF
Multimodal profiling for prediction of primary resistance to anti-PD-(L)1 therapy in advanced non-small-cell lung cancer: the prospective PIONeeR biomarkers study
2026 · Fabrice Barlesi, Florence Monville, et al. · medRxiv
PDF
Metamats: A mechanistic software for the simulation, inference and prediction of clinical metastasis
2025 · Bigarré, Célestin, Daumas, Alice, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
PDF
Predicting survival and trial outcome in non-small cell lung cancer integrating tumor and blood markers kinetics with machine learning
2023 · Sébastien Benzekry, Mélanie Karlsen, et al. · medRxiv
PDF
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers
2022 · BIGARRÉ, Célestin, Bertucci, François, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
Abstract 2737: A mechanistic model for prediction of metastatic relapse in early-stage breast cancer using routine clinical features
2022 · Célestin Bigarré, Pascal Finetti, et al. · Cancer Research
Works count: 8
Citation count: 17
H-index: 2
I10-index: 1
Year
Topic
Type